EPI-589 Uses, Dosage, Side Effects and more
EPI-589 is under investigation in clinical trial NCT02460679 (Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS)).
| Trade Name | EPI-589 |
| Generic | EPI-589 |
| Type | |
| Formula | C14H19NO4 |
| Weight | Average: 265.309 Monoisotopic: 265.131408096 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
